Fabian Hansen
Fondateur chez Presight Capital
Profil
Fabian Hansen is the founder of Presight Capital, a venture capital firm founded in 2019, where he holds the title of General Partner.
He is currently a Director at Alloy Therapeutics LLC.
In addition, he is a Board Member at Peptilogics, Inc. since 2020 and at Angiex, Inc. since 2021.
Previously, he served as a Board Member at Grupo Valoreo SA de CV from 2021 to 2023.
Mr. Hansen has a graduate degree from the London School of Economics & Political Science and an undergraduate degree from Royal Holloway University of London.
Postes actifs de Fabian Hansen
| Sociétés | Poste | Début |
|---|---|---|
Presight Capital
 Presight Capital Investment ManagersFinance Presight Capital Management Co LLC (Presight Capital) is a venture capital subsidiary of Apeiron Investment Group Ltd founded in 2019 by Christian Angermayer and Fabian Hansen. The firm is headquartered in West Hollywood, California. | Fondateur | 01/01/2019 |
Alloy Therapeutics LLC
 Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Peptilogics, Inc.
 Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | 01/12/2020 |
Angiex, Inc.
 Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/03/2021 |
Anciens postes connus de Fabian Hansen
| Sociétés | Poste | Fin |
|---|---|---|
Grupo Valoreo SA de CV
 Grupo Valoreo SA de CV Financial ConglomeratesFinance Part of Razor Group GmbH, Grupo Valoreo SA de CV is a next-gen consumer and e-commerce holding Mexican company. The company is based in Ciudad de Mexico, Mexico. The company has raised capital from some of the world's leading investment firms such as Upper90, FJ Labs, Angel Ventures, and Presight Capital, as well as prominent angel investors. The company was founded by Miguel Oehling, Cedrik Hoffmann, Stefan Florea, Alexander Gruell, Martin Florea, and Stefan Florea, Alexander Gruell, Martin Florea have been the CEOs since incorporation. Grupo Valoreo SA de was acquired by Razor Group GmbH on December 22, 2022. | Directeur/Membre du Conseil | 01/01/2023 |
Formation de Fabian Hansen
| London School of Economics & Political Science | Graduate Degree |
| Royal Holloway University of London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Presight Capital
Presight Capital Investment ManagersFinance Presight Capital Management Co LLC (Presight Capital) is a venture capital subsidiary of Apeiron Investment Group Ltd founded in 2019 by Christian Angermayer and Fabian Hansen. The firm is headquartered in West Hollywood, California. | Finance |
Alloy Therapeutics LLC
Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Commercial Services |
Peptilogics, Inc.
Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA. | Commercial Services |
Angiex, Inc.
Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
Grupo Valoreo SA de CV
Grupo Valoreo SA de CV Financial ConglomeratesFinance Part of Razor Group GmbH, Grupo Valoreo SA de CV is a next-gen consumer and e-commerce holding Mexican company. The company is based in Ciudad de Mexico, Mexico. The company has raised capital from some of the world's leading investment firms such as Upper90, FJ Labs, Angel Ventures, and Presight Capital, as well as prominent angel investors. The company was founded by Miguel Oehling, Cedrik Hoffmann, Stefan Florea, Alexander Gruell, Martin Florea, and Stefan Florea, Alexander Gruell, Martin Florea have been the CEOs since incorporation. Grupo Valoreo SA de was acquired by Razor Group GmbH on December 22, 2022. | Finance |
